Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study on the Application of Artificial Intelligence Model to Predict Diagnosis, Prognosis, and Molecular Alterations in Pancreatic Cancer

NCT07803770 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT07803770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07803770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study on the Application of Artificial Intelligence Model to Predict Diagnosis, Prognosis, and Molecular Alterations in Pancreatic Cancer
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
December 31, 2028
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence (ai), endoscopic ultrasound (eus), pancreatic ductal adenocarcinoma (pdac), pancreatic neoplasms, radiomics